Evidence map›Paper›PMID 16984635›Full record

ArticleBMC immunology2006

Novel insights in the regulation of CCL18 secretion by monocytes and dendritic cells via cytokines, toll-like receptors and rheumatoid synovial fluid.

Antoine W T van Lieshout, Robbert van der Voort, Linda M P le Blanc, Mieke F Roelofs, B Willem Schreurs, Piet L C M van Riel, Gosse J Adema, Timothy R D J Radstake

Open access · goldAbstract read
In one paragraph

Article in BMC immunology, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Serum and synovial fluid levels of CCL18 are correlated with radiographic grading of knee osteoarthritis.Medical science monitor : international medical journal of experimental and clinical research · 2015
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Chemokines and chemokine receptors in arthritis.Frontiers in bioscience (Scholar edition) · 2010
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Developments in the synovial biology field 2006.Arthritis research & therapy · 2007
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Antoine W T van LieshoutDepartment of Rheumatology, Radboud University Nijmegen Medical Centre, The Netherlands. a.vanlieshout@reuma.umcn.nl
Robbert van der Voort
Linda M P le Blanc
Mieke F Roelofs
B Willem Schreurs
Piet L C M van Riel
Gosse J Adema
Timothy R D J Radstake
Radboud University Medical Center · NLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe T cell attracting chemokine CCL18 is produced by antigen presenting cells and a role for CCL18 has been suggested in the pathogenesis of a variety of diseases. Rheumatoid arthritis (RA) is one of these conditions, in which abundant CCL18 production is present. Although Th2 cytokines and IL-10 are known to have an effect on CCL18 production, there are several gaps in our knowledge regarding the exact regulation of CCL18 secretion, both in general and in RA. In this study we provide new insights in the regulation of CCL18 secretion by monocytes and dendritic cells.

resultsIn contrast to a large panel of pro-inflammatory stimuli (IL-1beta, TNF-alpha, IL-10, IL-13, IL-15, IL-17, IL-18, IFN-gamma), T cell mimicking molecules (RANKL, CD40L) or TLR driven maturation, the anti-inflammatory IL-10 strongly stimulated DC to secrete CCL18. On freshly isolated monocytes, CCL18 secretion was induced by IL-4 and IL-13, in strong synergy with IL-10. This synergistic effect could already be observed after only 24 hours, indicating that not only macrophages and dendritic cells, but also monocytes secrete CCL18 under these stimulatory conditions. A high CCL18 expression was detected in RA synovial tissue and incubation of monocytes with synovial fluid from RA patients clearly enhanced the effects of IL-4, IL-13 and IL-10. Surprisingly, the effect of synovial fluid was not driven by IL-10 of IL-13, suggesting the presence of another CCL18 inducing factor in synovial fluid.

conclusionIn summary, IL-10 synergistically induces CCL18 secretion in combination with IL-4 of IL-13 on monocytes and monocyte derived cells. The effects of IL-14, IL-13 and IL-10 are strongly enhanced by synovial fluid. This synergy may contribute to the high CCL18 expression in RA.

Indexed as

Arthritis, RheumatoidCells, CulturedChemokines, CCCytokinesDendritic CellsDrug SynergismHumansInterleukin-10Interleukin-13Interleukin-4InterleukinsMonocytesSynovial FluidToll-Like ReceptorsCCL18 protein, humanChemokines, CCCytokinesInterleukin-10Interleukin-13Interleukin-4InterleukinsToll-Like Receptors

Identifiers

PMID16984635
PMCPMC1590050
OpenAlexW2142061266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.